Practitioner 2011;255 (1745):27-30

Diagnosing autism spectrum disorders in primary care

22 Nov 2011

AUTHORS

Dr Clare S Allely MA (Hons) MRes PhD
Research Assistant
Dr Philip Wilson DPhil MRCPCH FRCGP
GP and Senior Lecturer, Institute of Health and Wellbeing, University of Glasgow, RHSC Yorkhill, Glasgow

Article

Autism is a disorder of social communication, first described by Kanner in 19431 as a triad of impaired social interaction, communication, and imagination, associated with a rigid, repetitive pattern of behaviour. More recently the core deficit has been described as a lack of social instinct.2,3

Autism, like most psychiatric disorders, covers a spectrum of severity from severely disabling classic autism to milder forms of Asperger’s syndrome which border on normality. The term autism spectrum disorder (ASD) includes autism, atypical autism and Asperger’s syndrome.

Some parents consult their GP worried that their child might have autism. Others may attend with a range of concerns that might point to the condition such as problems with hearing, vision, hypersensitivity to sensory stimuli, behaviour management, language impairment or repetitive behaviour.

Autism conditions often co-exist with neurological disorders (particularly those including epilepsy), and more than 300 syndromes which include autism have been described.4

The new NICE guidelines, launched in September 2011,5 cover children, from birth up to 19 years, on the autism spectrum and build on the guidance published by SIGN in 2007.6

ASD was once believed to be relatively rare but is now thought to occur in about 1% of children.7,8 There is certainly increasing demand for diagnostic services for children and young people. Whether the apparent increasing prevalence9 signifies an epidemic or an epidemic of discovery10 is debatable.

Diagnostic criteria

The two primary diagnostic classification systems currently in use are the ICD-1011 and the DSM-IV.12 The ICD-10 is the most commonly used ASD classification system in the UK and forms the basis for the SIGN guideline.6

The DSM-IV, published by the American Psychiatric Association in 1994, defines autistic disorder by the presence of deficits or unusual behaviours within the following three domains together with onset before the age of three:

• reciprocal social interaction

• communication

• restricted, repetitive interests and behaviours

For the revised fifth edition of the DSM, there are proposed changes in the diagnosis of ASD.13 The revised criteria include only two symptom domains (social-communication and fixated, repetitive interests), the elimination of ASD subtypes, and the categorisation of individual differences in terms of dimensions of severity in the two domains.14 Some authorities consider that the proposed changes undervalue the importance of deficits in social imagination, and may lead to underdiagnosis in infancy, adulthood and in girls and women.15

Risk factors

There is a substantial genetic basis with strong heritability.16,17 Approximately 70% of individuals with ASD also meet diagnostic criteria for at least one other (often unrecognised) mental and behavioural disorder.18

Factors associated with an increased prevalence of ASD are listed in table 1, left. Sleep problems in children and young people with ASD are also reported more frequently by parents. 19-23

SIGN states that GPs should be aware of the importance of considering comorbid problems in children and young people with ASD.6

Referral

The NICE guidelines recommend the provision of an autism team in each area with a core membership consisting of: a paediatrician and/or child and adolescent psychiatrist, a speech and language therapist and a clinical and/or educational psychologist. In the absence of such a team, GP referrals would normally be to a paediatrician or a child or adolescent psychiatrist. The decision to refer should be made on the basis of signs or symptoms. However, there is also a need to consider the range, number, severity, duration, pervasiveness and impact of these signs and symptoms.

Particular attention should be paid to the degree of parental concern.

With consent from parents or carers, and if appropriate the patient, information should be gathered from schools or other agencies. Before diagnosis, children may be labelled as ‘naughty’ and may also be underachieving, misunderstood and unsupported.

They may also experience anxiety and distress about attending school or may even be excluded from school.

Caution must, however, be exercised since the contribution of information from teachers and schools towards accurate diagnosis has not been thoroughly tested.6

With consent, sharing the profile or diagnostic assessment with professionals in education (for example through a school visit by a member of the autism team) can provide important information which contributes to the design of the individual education plan and needs-based management plan.5 By informing the school, additional support for learning (ASL) can also be implemented. Provision of this support is the responsibility of educational services.

Referral decisions should also take into consideration the presence of risk factors, see table 1, above. In cases where the signs and symptoms are not sufficient to warrant an immediate referral, NICE recommends that a healthcare professional should consider keeping a close eye on the individual as they mature since signs and symptoms may change during this time. If the parent, carer or healthcare professional remains concerned, then a referral needs to be reconsidered.

The NICE guidelines also state that children younger than three years should be referred to an autism team if there is regression in language or social skills. However, these teams are not universally accessible throughout the UK. In children older than three with regression in language or motor skills, referral should be to a paediatrician or paediatric neurologist in the first instance.

Irrespective of any earlier assessments, re-referral for further ASD assessment should be considered at any age.6 ASD should not be ruled out because of: good eye contact; smiling and showing affection to family members; reported pretend play or apparently normal language development.5

Early recognition

The evidence that early intervention in ASD is better than later intervention in terms of developmental outcomes is relatively weak, and parents rather than children may be the principal beneficiaries. Nevertheless, early assessment for health problems and developmental disorders is likely to be desirable.6 Early identification of, and intervention for, developmental problems in general can improve outcomes as well as alleviating parental anxiety.24 The evidence for developmental benefits of early intervention in ASD is largely based on observational studies.25,26

Recognition and diagnosis may lead to the provision of autism-specific support to families, financial benefits and sometimes more appropriate education, which can lead to better outcomes for the individual.5

It should always be borne in mind that an incorrect diagnosis of ASD, and sometimes even a correct diagnosis, in the absence of significant functional impairment, can carry a risk of harm to families. Early detection research can nevertheless allow new insights into the developmental mechanisms underlying risk of ASD, produce new treatment strategies aimed at restoring developmental trajectories and reduce or prevent long-term disability.27

Diagnostic assessment

There is no specific diagnostic test for ASD. Diagnosis is based primarily on the recognition and interpretation of behavioural symptoms.28 According to the NICE guidelines, diagnostic assessment should start within three months of referral. Information from all sources (i.e. medical history, parental concerns, clinical judgement) should be used to diagnose ASD based on

ICD-10 or DSM-IV criteria. It is not advisable to rely on any one autism-specific diagnostic tool alone to diagnose ASD.

Based on physical examination, clinical judgement and the child or young person’s profile, genetic tests may be performed if there are specific dysmorphic features, congenital anomalies and/or evidence of intellectual disability. EEG may be useful if epilepsy is suspected.5 Parents should have an opportunity to discuss the risk of ASD occurring in siblings and future children.

The minimum age at which ASD can be reliably diagnosed remains uncertain. There is a wealth of evidence concerning the manifestations of ASD between the ages of one and three years.29,30 In children under two years typical ASD behaviours may not, however, always be evident. Some of the very early symptoms of autism include deficits in reciprocal social interaction and communication, repetitive behaviours, deficits in imitation, spontaneous and pretend play, and joint attention.31-33 The possibility of diagnosis should not be ruled out in the absence of typical ASD behaviours.34

Accuracy of assessment tools

There is a multiplicity of structured autism diagnostic assessment tools see box 1, above. Assessments of intellectual ability and/or receptive and expressive language also complement these assessment tools.5

The combination of ADI/ADI-R and ADOS is accurate in diagnosing autism in preschool children and children with an intellectual disability.

Overall, evidence supporting the use of autism-specific diagnostic tools, either individually or in combination, is poor, so the clinical benefits of using these tools remain uncertain. The NICE guidelines nevertheless acknowledged that both an autism-specific semi-structured interview and observation are effective in implementing a structured means of collating information to aid diagnostic assessment.

The Checklist for Autism in Toddlers (CHAT) or the modified version (M-CHAT) are simple checklists that can be used for the assessment of young children in primary care by GPs or health visitors when ASD is suspected. They can identify clinical features indicative of increased risk but should not be used to rule out ASD.6 The M-CHAT is a promising instrument for the early detection of ASD.35 It fails to recognise 15% of children with the condition.36

Interventions

A comprehensive evaluation of speech and language and communication skills of all children and young people with ASD should be carried out in order to inform intervention. An individual’s level of comprehension may be at a lower developmental level than that suggested by their expressive language skills. There is often a range of further impairments in intellectual, neuropsychological and adaptive skills and so occupational therapy and physiotherapy assessments should be considered where relevant.6

The majority of intensive behavioural programmes for ASD are based on the principles of behaviour modification using applied behavioural analysis (ABA). These programmes can be very intensive and expensive, usually involving 20 to 40 hours of intervention per week for preschool children. The Lovaas programme37,38 is the best known ABA. Further interventions are designed to support social communication and interaction directly, e.g. visual timetabling, operationalising through short stories or the use of speech bubbles or cartoons. Published evidence for these interventions is generally weak.39,40

Various pharmacological interventions are discussed in the SIGN guidelines.

• Risperidone can be useful for short-term treatment of significant aggression, tantrums or self-injury in children with ASD, but weight should be monitored regularly.

• Methylphenidate may be considered for treatment of attention difficulties or hyperactivity.

• Melatonin may also be considered for treatment of sleep problems which have persisted despite behavioural interventions.

• A single trial found statistically significant but relatively small clinical benefit from fluoxetine on repetitive behaviours in children and young people with ASD. Side effects were similar to placebo.41

• Naltrexone and secretin appear ineffective and are not recommended.

A thorough Cochrane systematic review looked at biomedical and nutritional interventions and was unable to identify an evidence base for or against casein and gluten exclusion diets.42 Gastrointestinal symptoms, which are common in children and young people with ASD, should be managed in the same way as in children and young people without ASD.

Conclusion

When making a referral decision in a suspected case of ASD, a broad range of issues need to be considered. These include parental concerns, the impact of symptoms on the family, educational factors, medical conditions with an increased risk of ASD, and the likelihood of an alternative diagnosis.

Account needs to be taken of the severity and duration of the signs and/or symptoms and the degree to which these are manifest in various settings (i.e. home and school).

GPs can help support the child and family before and after diagnosis is confirmed. Clear information on support available locally should be provided, and opportunities given for the family to ask questions. Contact information for local and national support organisations is likely to be of particular value, as well as information about organisations that can provide advice on welfare benefits, educational support, social care and preparing for the future. Children and their parents should routinely receive written information, perhaps including copies of the letters sent to the various professionals who have been asked to assess their child.

Finally, encouragement should be given to children, young people and their parents to continue to learn about ASD.

REFERENCES

1 Kanner L. Autistic disturbances of affective contact. Nerv Child 1943;2(3):217-50

2 Wing L, Gould J. Severe impairments of social-interaction and associated abnormalities in children - epidemiology and classification. J Autism Dev Disord 1979;9(1):11-29

3 Wing L. Reflections on opening Pandora's box. J Autism Dev Disord 2005;35(2):197-203

4 Wegner LM. The biology of the autistic syndromes, 3rd edition. J Dev Behav Pediatr 2004;25(5):364-5

5 National Institute for Health and Clinical Excellence. (CG128) Autism: recognition, referral and diagnosis of children and young people on the autism spectrum. NICE. London. 2011

6 Scottish Intercollegiate Guidelines Network. SIGN 98. Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders. A national clinical guideline. SIGN. Edinburgh. 2007

7 Baird G, Simonoff E, Pickles A et al. Prevalence of disorders of the autism spectrum in a population cohort of children

in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368(9531):210-5

8 Baron-Cohen S, Scott FJ, Allison C et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009;194(6):500-9

9 Dawson G. Commentary: The Changing Face of Autism Requires Rethinking Policy Needs. Social Policy Report 2010;24(2):22-3

10 Grinker RR. Unstrange minds: Remapping the world of autism. Basic. New York. 2007

11 World Health Organization (WHO). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. WHO. Geneva. 1993

12 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn)

(DSM-IV). APA. Washington, DC. 1994

13 American Psychiatric Association (APA). DSM-5 development. www.dsm5.org. 2010

14 Lord C and Bishop SL. Autism Spectrum Disorders Diagnosis, Prevalence, and Services for Children and Families. Social Policy Report 2010;24(2):3-21

15 Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: Better or worse than the

DSM-IV? Res Dev Disabil 2011;32(2):768-73

16 Bailey A, Lecouteur A, Gottesman I et al. Autism as a strongly genetic disorder - evidence from a British twin study. Psychol Med 1995;25(1):63-77

17 Folstein SE, Rutter ML. Autism: Familial aggregation and genetic-implications. J Autism Dev Disord 1988;18(1):3-30

18 Stanfield AC, McIntosh AM, Spencer MD et al. Towards a neuroanatomy of autism: A systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry 2008;23(4):289-99

19 Allik H, Larsson JO, Smedje H. Sleep patterns of school-age children with Asperger syndrome or high-functioning autism. J Autism Dev Disord 2006 ;36(5): 585-95

20 Cotton S, Richdale A. Brief report: Parental descriptions of sleep problems in children with autism, Down syndrome, and Prader-Willi syndrome. Res Dev Disab 2006;27(2):151-61

21 Couturier JL, Speechley KN, Steele M et al. Parental perception of sleep problems in children of normal intelligence with pervasive developmental disorders: Prevalence, severity, and pattern. J Am Acad Child Adolesc Psychiatry 2005;44(8):815-22

22 Honomichl RD, Goodlin-Jones BL, Burnham M et al. Sleep patterns of children with pervasive developmental disorders. J Autism Dev Disord 2002;32(6):553-61

23 Noterdaeme M, Mildenberger K, Minow F, Amorosa H. Evaluation of neuromotor deficits in children with autism and children with a specific speech and language disorder. Eur Child Adolesc Psychiatry 2002;11(5):219-25

24 Bailey DB, Hebbeler K, Spiker D et al. Thirty-six-month outcomes for families of children who have disabilities and participated in early intervention. Pediatrics 2005;116(6):1346-52

25 Ben-Itzchak E, Zachor DA. The effects of intellectual functioning and autism severity on outcome of early behavioral intervention for children with autism. Res Dev Disabil 2007;28(3):287-303

26 Harris SL, Handleman JS. Age and IQ at intake as predictors of placement for young children with autism: A four- to six-year follow-up. J Autism Dev Disord 2000;30(2):137-42

27 Dawson G. Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev Psychopathol 2008;20(3):775-803

28 Liu KY, King M, Bearman PS. Social influence and the autism epidemic. Am J Sociol 2010;115(5):1387-434

29 Goin RP, Myers BJ. Characteristics of infantile autism: Moving toward earlier detection. Focus on autism and other developmental disabilities 2004;19(1):5-12

30 Zwaigenbaum L, Bryson S, Rogers T et al. Behavioral manifestations of autism in the first year of life. Int J Dev Neuroscience 2005;23(2-3):143-5

31 Charman T, Swettenham J, Baron-Cohen S et al. An experimental investigation of social-cognitive abilities in infants with autism: Clinical implications. Infant Mental Health J 1998;19(2):260-75

32 Dawson G, Osterling J, Meltzoff AN, Kuhl P. Case study of the development of an infant with autism from birth to two years of age. J Appl Dev Psychology 2000;21(3):299-313

33 Maestro S, Muratori F, Cesari A et al. Course of autism signs in the first year of life. Psychopathology 2005; 38(1):26-31

34 Tebruegge MNV and RJ. Does routine child health surveillance contribute to the early detection of children with pervasive developmental disorders? An epidemiological study in Kent, U.K. BMC Pediatrics 2004;4(1):1-7

35 Robins DL, Fein D, Barton ML, Green JA. The modified checklist for autism in toddlers: An initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord 2001;31(2):131-44

36 Al-Qabandi M, Gorter JW, Rosenbaum P. Early autism detection: Are we ready for routine screening? Pediatrics 2011;128(1):e211-e217

37 Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 1987;55(1):3-9

38 Mceachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993;97(4):359-72

39 Silver M, Oakes P. Evaluation of a new computer intervention to teach people with autism or Asperger syndrome to recognize and predict emotions in others. Autism 2001;5(3):299-316

40 Wellman HM, Baron-Cohen S, Caswell R et al. Thought-bubbles help children with autism acquire an alternative to a theory of mind. Autism 2002;6(4):343-63

41 Hollander E, Phillips A, King BH et al. Impact of recent findings on study design of future autism clinical trials. CNS Spectr 2004;9(1):49-56

42 Milllward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2008;(2) 

FURTHER READING

 

USEFUL INFORMATION

NICE CG128: Autism: Recognition, referral and diagnosis of children and young people on the autism spectrum

www.nice.org.uk

SIGN 98: Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders

www.sign.ac.uk

Web-based learning resource for primary care practitioners

www.nes.scot.nhs.uk/asd

The National Autistic Society

www.autism.org.uk

‘Transition: getting it right for young people’

www.dh.gov.uk

CLICK ON IMAGES

 

RELATED FILES

The following files will open in their associated programs.

Table 1 Risk factors for ASDKey pointsBox 1 Assessment tools

PRESET SEARCHES

PubMed

Autism spectrum children

NICE Evidence

Autism spectrum children